Table 1.

NEP Protein Expression in Melanoma Specimens Tested by Immunohistochemistry

Disease Stage:	Specimens tested (n)	NEP overexpression (n)	NEP overexpression (%)
Primary	33	1	3%
Metastatic
Lymph Node	27	7	26%
Skin/Subcutaneous	19	6	32%
Visceral	8	4	50%
Primary biopsy from metastatic patients	6	1	17%
Total	60	18	30%